1. Repository of OAI
Ελληνικά   English  

Browsing by Author Mikhailidis, D. P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 104 to 123 of 130 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT studyAthyros, V. G.; Giouleme, O.; Ganotakis, E. S.; Elisaf, M. S.; Tziomalos, K.; Vassiliadis, T.; Liberopoulos, E. N.; Theocharidou, E.; Karagiannis, A.; Mikhailidis, D. P.24-Nov-2015-
Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patientsManousou, P.; Kalambokis, G.; Grillo, F.; Watkins, J.; Xirouchakis, E.; Pleguezuelo, M.; Leandro, G.; Arvaniti, V.; Germani, G.; Patch, D.; Calvaruso, V.; Mikhailidis, D. P.; Dhillon, A. P.; Burroughs, A. K.24-Nov-2015-
Serum uric acid levels and risk for acute ischaemic non-embolic stroke in elderly subjectsMilionis, H. J.; Kalantzi, K. J.; Goudevenos, J. A.; Seferiadis, K.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Should a statin be prescribed to every patient with heart failure?Tsouli, S. G.; Liberopoulos, E. N.; Goudevenos, J. A.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetesFlorentin, M.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Smoking diminishes the beneficial effect of statins: observations from the landmark trialsMilionis, H. J.; Rizos, E.; Mikhailidis, D. P.24-Nov-2015-
Statin treatment may be beneficial to both the kidneys and the heartAthyros, V. G.; Karagiannis, A.; Liberopoulos, E. N.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Statin-associated adverse effects beyond muscle and liver toxicityKiortsis, D. N.; Filippatos, T. D.; Mikhailidis, D. P.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?Athyros, V. G.; Tziomalos, K.; Daskalopoulos, G. N.; Karagiannis, A.; Mikhailidis, D. P.24-Nov-2015-
Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease PatientsAthyros, V. G.; Kakafika, A. I.; Papageorgiou, A. A.; Pagourelias, E. D.; Savvatianos, S. D.; Elisaf, M. S.; Karagiannis, A.; Tziomalos, K.; Mikhailidis, D. P.24-Nov-2015-
Statins and renal functionElisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Statins and renal function in patients with diabetes mellitusAthyros, V. G.; Papageorgiou, A. A.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Statins and renal function. Is the compound and dose making a difference?Athyros, V. G.; Karagiannis, A.; Kakafika, A.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Statins and solid organ transplantationGazi, I. F.; Liberopoulos, E. N.; Athyros, V. G.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Statins for non-alcoholic fatty liver disease: a new indication?Liberopoulos, E. N.; Athyros, V. G.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Statins: another class of antihypertensive agents?Milionis, H. J.; Liberopoulos, E. N.; Achimastos, A.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Targeting vascular risk in patients with metabolic syndrome but without diabetesAthyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Didangelos, T. P.; Peletidou, A.; Kleta, D.; Karagiannis, A.; Kakafika, A. I.; Tziomalos, K.; Elisaf, M. S.24-Nov-2015-
Targets for low-density lipoprotein cholesterol levels in patients with stable coronary heart disease: where are we now after the "treating to new targets" (TNT) trial?Liberopoulos, E. N.; Athyros, V. G.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Treating dyslipidaemia in non-insulin-dependent diabetes mellitus -- a special reference to statinsPapadakis, J. A.; Milionis, H. J.; Press, M.; Mikhailidis, D. P.24-Nov-2015-
Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study)Milionis, H. J.; Rizos, E.; Kostapanos, M.; Filippatos, T. D.; Gazi, I. F.; Ganotakis, E. S.; Goudevenos, J.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Showing results 104 to 123 of 130 < previous   next >